53
Research Trials
20
Peer-reviewed publications
16
Clinical Conditions
Hyfe pilot study tests a digital therapeutic combining passive cough monitoring with behavioral suppression techniques delivered through the CoughPro app.
This narrative review by Hyfe's R&D team makes the case that continuous cough monitoring (CCM), powered by acoustic AI, transforms cough from a subjective symptom into a quantifiable digital biomarker.
Independent ERS 2025 NeuroCOUGH trial uses the Hyfe Cough Tracker to test feasibility of studying azithromycin's effect on cough and oesophageal motility.
Independent ERS 2025 trial uses the Hyfe Cough Tracker to show azithromycin reduces objective cough frequency by week one in chronic respiratory disease.
23.03.2022
This paper emphasizes the urgent need for rapid, accurate, sputum-free tuberculosis (TB) diagnostic tests. It reviews key technologies like artificial intelligence-based automated digital chest X-radiography and capillary blood point-of-care assays. Technologies such as artificial intelligence-based methods are particularly promising, with Hyfe featured as a potential rapidly scalable, and rapid screening tool for cough sound specimens.The paper discusses the challenges in the diagnostic pipeline, including a shortage of community-based tools and the difficulty in detecting paucibacillary TB. It also highlights the importance of designing and evaluating assays for optimal programmatic uptake, and leveraging the urgency and innovation from COVID-19 response for improving TB diagnostics
